Engineers Gate Manager’s Ambrx Biopharma Inc AMAM Stock Holding History

Engineers Gate Manager’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,388	Closed	-$176K	–	2398
2023 Q4	$176K	Buy	+12,388	New	+$141K	0.01%	1670

Engineers Gate Manager's AMAM Position: Q1 2024 in Review

Engineers Gate Manager sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 12,388 shares — an estimated $176K sold.

Engineers Gate Manager first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $176K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Engineers Gate Manager reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Engineers Gate Manager sold 12,388 Ambrx Biopharma Inc shares in Q1 2024, an estimated $176K.
Engineers Gate Manager first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Engineers Gate Manager's Ambrx Biopharma Inc position peaked at $176K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.